Loading data
CLSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 12.39 bn USD | 9.65 bn USD | 7.96 bn USD | 7.25 bn USD |
| Cost of revenue | 10.9 bn USD | 8.61 bn USD | 7.21 bn USD | 6.6 bn USD |
| Gross profit | 1.49 bn USD | 1.03 bn USD | 754.1 m USD | 649.7 m USD |
| Research and development expense | 118.2 m USD | 78 m USD | 60.9 m USD | 46.3 m USD |
| Selling, general and administrative expense | 259.9 m USD | 293.5 m USD | 303.2 m USD | 267.3 m USD |
| Operating profit | 1.04 bn USD | 599.3 m USD | 338.3 m USD | 289.3 m USD |
| Profit before tax | 983.2 m USD | 532.2 m USD | 306 m USD | 239.1 m USD |
| Income tax expense | 150.7 m USD | 104.2 m USD | 61.6 m USD | 59 m USD |
| Net income (reported basis) | 832.5 m USD | 428 m USD | 244.4 m USD | 180.1 m USD |
| Basic earnings per share | 7.22 USD/share | 3.62 USD/share | 2.03 USD/share | 1.46 USD/share |
| Diluted earnings per share | 7.16 USD/share | 3.61 USD/share | 2.03 USD/share | 1.46 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.